Friday, 27 July 2018

AstraZeneca's key lung cancer drug wins European panel thumbs-up

AstraZeneca's cancer drug Imfinzi has won a key recommendation from a European Medicines Agency (EMA) panel less than six months after the first global approvals in Western markets.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)